Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders
Condition: Stem Cell Transplantation Interventions: Drug: Fludarabine; Drug: Dexamethasone; Drug: Cyclophosphamide; Drug: Bortezomib; Drug: Rituximab; Drug: Busulfan; Drug: Cyclophosphamide (Cy); Drug: Tacrolimus (or cyclosporine); Drug: Mycophenolate mofetil (MMF); Drug: Rabbit ATG Sponsor: M.D. Anderson Cancer Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer & Oncology | Dexamethasone | Hematology | Research | Restasis | Rituxan | Stem Cell Therapy | Stem Cells | Toxicology | Transplants | Velcade